Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Abroad (travel likely)RecruitingPHASE3

Conditions

Nasopharyngeal Carcinoma (NPC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Contact: Study coordinator (Min Kang, MD) · kangmin@gxmu.edu.cn · +86-771-5356509

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Fuzhou, China · Xiamen, China

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma · Nasopharyngeal Cancer · Nasopharyngeal Neoplasms

Abroad (travel likely)RecruitingPHASE2

Aachen, Germany · Aachen, Germany

Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.

Nasopharyngeal Carcinoma · De-escalation Therapy

Abroad (travel likely)RecruitingPHASE3

Zhuhai, China

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China · Guangzhou, China